| QURE | CLUSTER | neutral | 3/10 | Nine insiders at uniQure N.V. (QURE) sold a total of $1.2M in shares over a 7-day window, representing approximately 0.0 | Jun 17, 2026 |
| KROS | CLUSTER | neutral | 2/10 | Two KROS directors made minor opposing trades: Bienaime purchased $10K worth of shares while Newton sold $6K. Total insi | Jun 17, 2026 |
| JAZZ | CLUSTER | neutral | 2/10 | Two Jazz Pharmaceuticals insiders (a director and the EVP & Chief Legal Officer) sold a combined $545K in open-market tr | Jun 17, 2026 |
| ABEO | CLUSTER | neutral | 4/10 | Five ABEO insiders, including the CEO and CFO, sold a total of $407K in shares over a 7-day window. The selling represen | Jun 17, 2026 |
| ADTX | CLUSTER | bearish | 5/10 | Insider cluster at Aditxt (ADTX) shows mixed activity: HRT Financial LP bought ~$97.6K in two open-market purchases but | Jun 17, 2026 |
| KRRO | CLUSTER | neutral | 3/10 | Four senior insiders at Korro Bio (COO, CSO, SVP Finance, General Counsel) sold a total of $180K in open-market sales on | Jun 17, 2026 |
| DYN | CLUSTER | neutral | 2/10 | Three top executives (CEO, CMO, CCO) at Dyne Therapeutics sold a combined ~$68K in shares on June 16, 2026, the same day | Jun 17, 2026 |
| UPB | CLUSTER | neutral | 2/10 | Five Upstream Bio insiders (CEO, CFO/COO, CMO, CBO, General Counsel) sold a combined ~$31K worth of UPB stock on a singl | Jun 17, 2026 |
| ANIX | CLUSTER | bullish | 4/10 | Two Anixa insiders, including CEO Amit Kumar, made open-market purchases totaling ~$60K over a 5-day window. While the d | Jun 17, 2026 |
| ONMD | CLUSTER | bullish | 6/10 | Three insiders (CEO, CMO, and a Director) made open-market purchases totaling ~$210K over five days, with the CEO buying | Jun 17, 2026 |
| GILD | CLUSTER | neutral | 2/10 | Two GILD executives (CFO and Chief Communications & Corporate Affairs Officer) sold a combined $559K in open-market shar | Jun 16, 2026 |
| HOWL | CLUSTER | bearish | 6/10 | Two insiders at Werewolf Therapeutics (HOWL) sold shares in a cluster, including Director Luke Evnin and 10% owner RA Ca | Jun 16, 2026 |
| IONS | CLUSTER | neutral | 2/10 | Two IONIS insiders (a Director and the EVP/Chief Development Officer) sold a combined $3.59M in open-market shares after | Jun 16, 2026 |
| TVTX | CLUSTER | neutral | 2/10 | Two directors of Travere Therapeutics (TVTX) exercised stock options and immediately sold the resulting shares on June 1 | Jun 16, 2026 |
| PCSA | CLUSTER | bullish | 5/10 | Four C-suite insiders at Processa Pharmaceuticals (CEO, CFO, Chief Administrative Officer, Chief Business Strategy Offic | Jun 16, 2026 |
| PCSA | CLUSTER | bullish | 4/10 | Two C-suite insiders at Processa Pharmaceuticals (PCSA) made small open-market purchases totaling ~$9K on June 15, 2026, | Jun 16, 2026 |
| USNA | CLUSTER | neutral | 2/10 | Two C-suite insiders at USANA Health Sciences (USNA) sold a combined $135K in open-market sales over a one-week window. | Jun 16, 2026 |
| ADTX | CLUSTER | mixed | 5/10 | Aditxt insiders show mixed activity: HRT Financial LP net purchased ~2.1M shares (~$28K net) while Gong Sandie sold 100K | Jun 16, 2026 |
| TEVA | CLUSTER | neutral | 2/10 | Two top executives at Teva (CEO and CFO) sold a combined $3.84M in shares over a one-week window, but the total represen | Jun 16, 2026 |
| ONMD | CLUSTER | bullish | 6/10 | CEO Aaron Green and director/10% owner Thomas Kosasa made open-market purchases totaling $121K over a 7-day window, repr | Jun 16, 2026 |
| LGND | CLUSTER | neutral | 2/10 | Three directors sold a total of ~$1.95M in LGND shares over a 7-day window, representing only ~0.04% of the company's $5 | Jun 15, 2026 |
| PBYI | CLUSTER | neutral | 2/10 | Two directors at PUMA BIOTECHNOLOGY sold a combined $242K in open-market shares on June 12, 2026, representing just 0.06 | Jun 15, 2026 |
| ADTX | CLUSTER | bearish | 7/10 | Insider cluster at Aditxt shows 10% owners HRT Financial LP and Gong Sandie selling a combined 2.93M shares for ~$47K, w | Jun 15, 2026 |
| IPSC | CLUSTER | neutral | 2/10 | A cluster of insider transactions at Century Therapeutics shows a net selling direction, but the total value is only ~$5 | Jun 15, 2026 |
| IPSC | CLUSTER | neutral | 2/10 | Century Therapeutics insiders engaged in routine non-cash director grants (74,000 shares each to five directors) and min | Jun 15, 2026 |
| ABEO | CLUSTER | bearish | 5/10 | Five ABEO insiders, including the CEO and CFO, sold a total of $407K in open-market sales over a 7-day window. The clust | Jun 15, 2026 |
| ADPT | CLUSTER | neutral | 2/10 | Two C-suite insiders at Adaptive Biotechnologies sold a combined $790K in shares over a one-week window, representing ju | Jun 15, 2026 |
| ORKA | CLUSTER | neutral | 3/10 | Two ORKA insiders, a director and the SVP of Finance, sold $1.01M in open-market shares ($882K of that from director Car | Jun 15, 2026 |
| ORKA | CLUSTER | neutral | 2/10 | Four Oruka Therapeutics insiders (CEO, COO, General Counsel, and a Director) sold a total of ~$2.67M in open-market tran | Jun 15, 2026 |
| RARE | CLUSTER | neutral | 2/10 | Two insiders at Ultragenyx sold a combined $97K in open-market transactions on June 15, 2026. The EVP/Chief Legal Office | Jun 15, 2026 |